GE HealthCare launches Allia Celeo interventional imaging system
GE HealthCare has launched Allia Celeo, a ceiling-mounted system with AI imaging. It carries CE marking in Europe, while its U.S. 510(k) review is still pending.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to TradingView, GE HealthCare Technologies has introduced Allia Celeo, an interventional imaging system with a ceiling-mounted design. The device uses AI to process images and promises consistent quality at a lower radiation dose. It is compatible with the OnWatch Predict remote monitoring service.
The system has CE marking and its 510(k) application in the U.S. is pending. It can already be sold in CE-marked regions, while U.S. revenue will depend on FDA clearance. The company also highlights compatibility with its own tools, such as Valve ASSIST 2 and Embo ASSIST.
why it matters
For markets this is a narrow story: the launch widens GE HealthCare's interventional imaging lineup, but no effect on financial results is visible yet. Key catalysts will be FDA clearance, first orders and any disclosed product revenue.
tags
instruments
sources
- GE HealthCare Technologies Inc. (GEHC) Launches Allia Celeo Interventional Imaging System — TradingView, 1 November 2026 at 17:35 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗